Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications
Investors 1
| Date | Name | Website |
| - | Altium Cap... | altiumcap.... |
Mentions in press and media 42
| Date | Title | Description | Source |
| 29.04.2024 | Seelos Therapeutics Announces Strategic Focus on Mental Heal... | -Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing business devel... | salamancap... |
| 29.11.2021 | iX Biopharma Signs Exclusive License Agreement For Wafermine... | iX Biopharma will receive an initial US$9 million upfront payment Eligible for up to US$239 million ... | marketscre... |
| 25.11.2021 | iX Biopharma Signs Exclusive License Agreement For Wafermine... | iX Biopharma will receive an initial US$9 million upfront payment Eligible for up to US$239 million ... | en.prnasia... |
| 24.11.2021 | Seelos Therapeutics : Announces Acquisition of an Exclusive ... | Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafe... | marketscre... |
| 24.11.2021 | Seelos Therapeutics : Agreement Includes the Option of up to... | - Agreement Includes the Option of up to an Additional $30 Million of Funding Contingent on Achievem... | marketscre... |
| 03.11.2021 | Psychedelics Offer Hope for Mental Disorders, Addiction | NetworkNewsWire Editorial Coverage NEW YORK, Nov. 3, 2021 /PRNewswire/ -- Global destigmatization, c... | salamancap... |
| 03.11.2021 | Psychedelics Offer Hope for Mental Disorders, Addiction | NEW YORK, Nov. 3, 2021 /PRNewswire/ -- Global destigmatization, changing regulations and an upswing ... | salamancap... |
| 02.09.2021 | Seelos Therapeutics Announces Appointment of Margaret Dalesa... | prnewswire... | |
| 01.09.2021 | Seelos Therapeutics Announces Senior Management Appointments | prnewswire... | |
| 09.08.2021 | Seelos Therapeutics Announces Mid-Year 2021 Business and Cli... | prnewswire... |
Show more